Chardan Healthcare Acquisition 2, the second blank check company formed by Chardan Capital targeting the healthcare industry, filed on Monday with the SEC to raise up to $85 million in an initial public offering.
The New York, NY-based company plans to raise $85 million by offering 8.5 million units at a price of $10. Each unit consists of one share of common stock and one warrant, exercisable for one half a share of common stock at $11.50. At the proposed deal size, Chardan Healthcare Acquisition 2 would command a market value of $106 million.
The company is led by Executive Chairman Gbola Amusa and CEO Jonas Grossman, both are Partners at Chardan Capital Markets and serve as Head of Healthcare Equity Research and Head of Capital Markets, respectively. Their previous SPAC, Chardan Healthcare Acquisition (PHGE), went public in December 2018 and completed its merger with BiomX in October 2019. BiomX closed Friday at $9.88, down 1% from IPO.
The New York, NY-based company was founded in 2018 and plans to list on the NYSE under the symbol CHAQ.U. Chardan Capital Markets is the sole bookrunner on the deal.
